Physicians have launched the world’s first mRNA lung cancer vaccine trial, marking a significant advancement in cancer treatment.
BioNTech developed the vaccine BNT116, which targets non-small cell lung cancer (NSCLC) by training the immune system to identify and attack tumor markers.
Conducted across seven countries, including Türkiye, the phase 1 trial involves 130 patients with varying stages of lung cancer and aims to eliminate cancer cells and prevent recurrence.
The trial uses mRNA technology similar to that in COVID-19 vaccines, potentially offering a less toxic alternative to traditional chemotherapy.
Experts view this trial as a groundbreaking step in cancer research, with the first patient in the UK receiving the vaccine recently.
Source : PhilNews24 | August 24, 2024
WORLD’S INITIAL LUNG CANCER VACCINE TRIAL KICKS OFF
You might be interested in
Latest from News
Under President Ferdinand R. Marcos Jr., teachers in the Philippines are now experiencing timely career advancement
The rehabilitation of EDSA will begin on Christmas Eve, with an eight-month timeline and a reduced
Malacañang assured consumers that PrimeWater services will continue despite the company’s change in ownership from the
President Marcos joined the DSWD’s Pag-Abot Program in Pasay City, where he served meals and distributed
The Land Transportation Office (LTO) will deploy two mobile command centers on the North Luzon Expressway